Literature DB >> 8844475

Increased expression of cytokines in liver and serum in patients with extrahepatic diseases.

H Fukuma1, S A Morshed, S Watanabe, N Uchida, T Ezaki, A Minami, H Matsuoka, S Hirabayashi, T Nakatsu, M Nishioka.   

Abstract

To determine whether the liver plays an immunological role in certain extrahepatic disorders, we investigated the expression of interleukin (IL)-1 beta, IL-6, interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha in 11 patients who had recovered from cholecystolithiasis, 12 patients with gastric cancer, 20 patients with chronic hepatitis, and 6 healthy controls. Cytokine mRNAs in the liver were detected by semiquantitative reverse transcribed-polymerase chain reaction. Serum cytokines and soluble IL-2 receptor (sIL-2R) were investigated by enzyme-linked immunosorbent assays. Increases in TNF-alpha, IL-6, IL-1 beta, and IFN-gamma mRNAs were found in the livers of patients with extrahepatic diseases. TNF-alpha and IL-6 peptides were increased in the sera of patients with gastric cancer. TNF-alpha in the sera and TNF-alpha mRNA in the liver were correlated in gastric cancer patients. Surprisingly, sIL-2R in the serum of gastric cancer patients was significantly higher than the level in healthy controls. Our findings suggest that the liver produces cytokines in reaction to extrahepatic lesions. Further, the increase in sIL-2R in gastric cancer patients indicates that malignancy may affect the immune network in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844475     DOI: 10.1007/bf02355054

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  30 in total

Review 1.  Polymerase chain reaction for detection of cytokine gene expression.

Authors:  A O'Garra; P Vieira
Journal:  Curr Opin Immunol       Date:  1992-04       Impact factor: 7.486

Review 2.  Tumour necrosis factor: roles in cancer pathophysiology.

Authors:  S T Malik
Journal:  Semin Cancer Biol       Date:  1992-02       Impact factor: 15.707

Review 3.  Interleukins and the immune system 2.

Authors:  A O'Garra
Journal:  Lancet       Date:  1989-05-06       Impact factor: 79.321

Review 4.  Liver-associated lymphocytes: role in tumor defense.

Authors:  M Winnock; M G Barcina; B Lukomska; P Bioulac-Sage; C Balabaud
Journal:  Semin Liver Dis       Date:  1993-02       Impact factor: 6.115

5.  Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats.

Authors:  M A Freudenberg; N Freudenberg; C Galanos
Journal:  Br J Exp Pathol       Date:  1982-02

6.  Preoperative and postoperative cytokines in patients with cancer.

Authors:  H Nakazaki
Journal:  Cancer       Date:  1992-08-01       Impact factor: 6.860

7.  Evidence for tumour necrosis factor/cachectin production in cancer.

Authors:  F Balkwill; R Osborne; F Burke; S Naylor; D Talbot; H Durbin; J Tavernier; W Fiers
Journal:  Lancet       Date:  1987-11-28       Impact factor: 79.321

Review 8.  The cytokine network.

Authors:  F R Balkwill; F Burke
Journal:  Immunol Today       Date:  1989-09

9.  Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis.

Authors:  J Napoli; G A Bishop; G W McCaughan
Journal:  Gastroenterology       Date:  1994-09       Impact factor: 22.682

10.  Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells.

Authors:  C B Siegall; G Schwab; R P Nordan; D J FitzGerald; I Pastan
Journal:  Cancer Res       Date:  1990-12-15       Impact factor: 13.312

View more
  6 in total

1.  Measurement of serum, liver, and brain cytokine induction, thiamine levels, and hepatopathology in rats exposed to a 4-day alcohol binge protocol.

Authors:  Natalie M Zahr; Richard Luong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

2.  Gallstones, cholecystectomy, and risk of digestive system cancers.

Authors:  Leticia Nogueira; Neal D Freedman; Eric A Engels; Joan L Warren; Felipe Castro; Jill Koshiol
Journal:  Am J Epidemiol       Date:  2014-01-26       Impact factor: 4.897

3.  Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas.

Authors:  W H Chow; C Johansen; G Gridley; L Mellemkjaer; J H Olsen; J F Fraumeni
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

4.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.

Authors:  Jessica L Petrick; Baiyu Yang; Sean F Altekruse; Alison L Van Dyke; Jill Koshiol; Barry I Graubard; Katherine A McGlynn
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

Review 5.  Target Elimination-Denatured and Unstable Proteins, Environmental Toxins, Metabolic Wastes, Immunosuppressive Factors and Chronic Inflammatory Factors of Medical System for Chronic Diseases Prevention and Health Promotion: A Narrative Review.

Authors:  Jiren Zhang; Zhaojing Jiang; Wenjuan Wei; Xufeng Li; Chen Sun; Yuanyuan Zhang; Shilin Fu; Jingfen Zheng
Journal:  Iran J Public Health       Date:  2019-06       Impact factor: 1.429

Review 6.  A systematic review of the association between circulating concentrations of C reactive protein and cancer.

Authors:  Katriina Heikkilä; Shah Ebrahim; Debbie A Lawlor
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.